Kraig Biocraft Laboratories (KBLB) Change in Accured Expenses (2010 - 2020)

Kraig Biocraft Laboratories (KBLB) has 11 years of Change in Accured Expenses data on file, last reported at -$27208.0 in Q2 2020.

• For the quarter ending Q2 2020, Change in Accured Expenses fell 51.02% year-over-year to -$27208.0; the trailing twelve-month figure through Jun 2020 stood at -$105358.0 (down 130.03% YoY), and the FY2019 full-year result was -$79609.0, down 111.66% from the prior year.
• Change in Accured Expenses declined to -$27208.0 in Q2 2020, from -$26647.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $569281.0 in Q3 2019 to a low of -$620784.0 in Q4 2019.
• A 5-year average of $58376.4 and a median of $127830.5 in 2016 frame the typical range for Change in Accured Expenses.
• Across the five-year window, Change in Accured Expenses tumbled 432.11% in 2017 and soared 278.61% in 2019, its largest moves.
• Tracing KBLB's Change in Accured Expenses over 5 years: stood at $122747.0 in 2016, then plunged by 432.11% to -$407659.0 in 2017, then surged by 156.08% to $228631.0 in 2018, then tumbled by 371.52% to -$620784.0 in 2019, then soared by 95.62% to -$27208.0 in 2020.
• Business Quant data shows KBLB's Change in Accured Expenses at -$27208.0 in Q2 2020, -$26647.0 in Q1 2020, and -$620784.0 in Q4 2019.